Prostate Cancer
Disease mapping: Geographic differences in population rates of interventional treatment for prostate cancer in Australia.
November 15, 2023
Robot-Assisted Radical Prostatectomy in Renal Transplant Recipients: A Systematic Review.
November 15, 2023
MR-guided prostate SBRT in prostate cancer patients with low-volume metastatic disease.
November 15, 2023
Association between prediagnostic PSA and prostate cancer probability in Black and non-Hispanic White men.
November 15, 2023
National long-term survival estimates after radical prostatectomy for prostate cancer.
November 14, 2023
Androgen receptor inhibition suppresses anti-tumor neutrophil response against bone metastatic prostate cancer via regulation of TβRI expression.
November 14, 2023
Social Media Interventions for Patients and Public: Opportunities and Challenges for the Urology Community
November 13, 2023
Determining clinical perspectives and strategies for improving enrollment of minoritized communities in prostate cancer clinical trials.
November 13, 2023
The impact of NCCN-compliant multidisciplinary conference on the uptake of active surveillance among eligible patients with localized prostate cancer.
November 13, 2023
Long-term Outcomes from a Phase 1 Dose Escalation Study Using Stereotactic Body Radiotherapy for Patients with Low- or Intermediate-risk Prostate Cancer.
November 13, 2023
Apalutamide efficacy, safety and wellbeing in older patients with advanced prostate cancer from Phase 3 randomised clinical studies TITAN and SPARTAN.
November 13, 2023
Radiation therapy margin reduction for patients with localized prostate cancer: A prospective study of the dosimetric impact and quality of life.
November 13, 2023
A contemporary review of the treatments and challenges associated with penile rehabilitation after radical prostatectomy including a proposed optimal approach.
November 10, 2023
Impact of the COVID-19 pandemic on delivery of prostate cancer care in Australia: An interrupted time series analysis.
November 10, 2023